Prema Cognition Founder Dr Julia Cooney named Forbes 30 Under 30
Dr Julia Cooney is working to improve dementia prevention through early, high-precision cognitive testing.
Prema Cognition is proud to announce that its founder and CEO, Dr Julia Cooney, has been named to the Forbes 30 Under 30 list, recognising her work in advancing early detection and prevention of cognitive decline.
At Prema Cognition, Dr Cooney is leading a shift in how dementia is identified and managed, moving from late-stage diagnosis toward earlier, proactive detection.
A medical doctor and biotechnologist, Dr Cooney spearheaded the development of PREMAZ, a digital cognitive assessment that translates more than a decade of neuroscience research from the University of Cambridge into a scalable clinical tool. Unlike traditional tests, PREMAZ measures “precision memory”, how accurately something is remembered, enabling the detection of subtle cognitive changes long before noticeable symptoms appear.
Since its founding in 2024, Prema Cognition has raised over $1.5 million in funding, including investment from SFC Capital, and is rapidly scaling across clinics in the UK and US. The company is currently running clinical studies and progressing toward regulatory approval, with the goal of making early cognitive screening more accessible and routine.
Dr Cooney’s inclusion in the Forbes 30 Under 30 list reflects both the growing importance of early brain health and the potential for new technologies to reshape how cognitive decline is understood and addressed.
As Prema Cognition continues to expand, its mission remains clear: to enable earlier detection, deeper understanding, and ultimately better prevention of cognitive decline.